RIGL

20.43

4.82% 0.94

시장 영업 전: 19.62 -0.81 -3.96%

Rigel Pharmaceuticals (RIGL)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 주식 분할

전일 마감가:

$19.49

열려 있는:

$19.87

하루 거래량:

194.55K

Relative Volume:

0.75

시가총액:

$364.94M

수익:

$116.88M

순이익/손실:

$-25.09M

주가수익비율:

-145.93

EPS:

-0.14

순현금흐름:

$-20.74M

1주 성능:

+0.69%

1개월 성능:

-1.87%

6개월 성능:

+57.76%

1년 성능:

+37.11%

1일 변동 폭

$19.00

$20.88

1주일 범위

$18.44

$20.94

52주 변동 폭

$7.4843

$29.82

Rigel Pharmaceuticals Stock (RIGL) Company Profile

명칭

Rigel Pharmaceuticals

부문

Healthcare (1172)

산업

Biotechnology (680)

전화

650-624-1100

주소

611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA

직원

164

트위터

@rigelpharma

다음 수익 날짜

2024-11-07

최신 SEC 제출 서류

RIGL's Discussions on Twitter

RIGL을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
RIGL Rigel Pharmaceuticals	20.43	364.94M	116.88M	-25.09M	-20.74M	-0.14
VRTX Vertex Pharmaceuticals Inc	495.42	127.22B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	689.50	75.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	591.45	35.94B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	242.43	31.38B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	249.84	26.84B	3.32B	-860.46M	-1.04B	-8.32

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-04-03	재개	Piper Sandler	Neutral
2022-06-09	다운그레이드	Citigroup	Buy → Neutral
2022-06-08	다운그레이드	Cantor Fitzgerald	Overweight → Neutral
2022-06-08	다운그레이드	Piper Sandler	Overweight → Neutral
2022-03-23	개시	B. Riley Securities	Neutral
2020-11-09	다운그레이드	JP Morgan	Overweight → Neutral
2019-11-15	재개	Cantor Fitzgerald	Overweight
2019-09-26	재개	JP Morgan	Overweight
2019-03-01	재확인	Cantor Fitzgerald	Overweight
2018-08-27	개시	Citigroup	Buy
2018-05-02	재확인	Cantor Fitzgerald	Overweight
2017-12-21	재개	Piper Jaffray	Overweight
2017-12-15	개시	Cantor Fitzgerald	Overweight
2017-11-06	재개	H.C. Wainwright	Buy
2017-03-09	재확인	H.C. Wainwright	Buy
2016-08-31	재확인	H.C. Wainwright	Buy
2016-08-30	재확인	Piper Jaffray	Overweight
2016-07-13	개시	H.C. Wainwright	Buy
2016-06-13	개시	Piper Jaffray	Overweight
2016-04-22	업그레이드	JP Morgan	Neutral → Overweight
2013-04-08	재확인	Stifel	Buy
2012-11-29	개시	UBS	Neutral
2012-11-06	재확인	Oppenheimer	Outperform
2012-03-26	개시	Canaccord Genuity	Hold
2010-12-10	다운그레이드	MP Advisors	Outperform → Market Perform

모두보기

Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스

Mar 12, 2025

Rigel Pharmaceuticals’ SWOT analysis: pipeline potential drives stock outlook - Investing.com

Mar 12, 2025

Mar 11, 2025

Rigel Looks Interesting, But Let's Wait For A Lower Price (NASDAQ:RIGL) - Seeking Alpha

Mar 11, 2025

Mar 10, 2025

Rigel Pharmaceuticals appoints new board member By Investing.com - Investing.com Canada

Mar 10, 2025

Rigel Pharmaceuticals adds oncology expert to board By Investing.com - Investing.com Australia

Mar 10, 2025

Rigel appoints Mark W. Frohlich to its board -March 10, 2025 at 12:01 pm EDT - Marketscreener.com

Mar 10, 2025

Rigel Pharmaceuticals appoints Mark W. Frohlich to board of directors - MSN

Mar 10, 2025

Rigel Pharmaceuticals adds oncology expert to board - Investing.com India

Mar 10, 2025

Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors - StockTitan

Mar 10, 2025

Mar 09, 2025

Rhumbline Advisers Has $423,000 Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Mar 09, 2025

Mar 08, 2025

FY2025 EPS Estimates for RIGL Increased by Cantor Fitzgerald - Defense World

Mar 08, 2025

Citigroup Forecasts Strong Price Appreciation for Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - Defense World

Mar 08, 2025

Rigel Pharmaceuticals Implements 1-for-10 Reverse Stock Split: Balancing Nasdaq Compliance and Investor Appeal - MSN

Mar 08, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded by StockNews.com to “Buy” - Defense World

Mar 08, 2025

What is B. Riley’s Forecast for RIGL Q1 Earnings? - Defense World

Mar 08, 2025

What is HC Wainwright’s Estimate for RIGL Q1 Earnings? - Defense World

Mar 08, 2025

Mar 07, 2025

Earnings call transcript: Rigel Pharmaceuticals Q4 2024 sees strong growth By Investing.com - Investing.com Australia

Mar 07, 2025

Rigel Pharmaceuticals, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance

Mar 07, 2025

Rigel Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

B. Riley Forecasts Strong Price Appreciation for Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - Defense World

Mar 07, 2025

HC Wainwright Reiterates Buy Rating for Rigel Pharmaceuticals (NASDAQ:RIGL) - Defense World

Mar 07, 2025

What is B. Riley’s Estimate for RIGL FY2026 Earnings? - Defense World

Mar 07, 2025

Q3 Earnings Forecast for RIGL Issued By HC Wainwright - Defense World

Mar 07, 2025

Mar 06, 2025

Rigel Pharmaceuticals price target raised to $55 from $49 at Citi - TipRanks

Mar 06, 2025

Mar 05, 2025

Rigel Pharmaceuticals Reports Record Sales and Strategic Growth - TipRanks

Mar 05, 2025

Wall Street Analysts Believe Rigel (RIGL) Could Rally 44.93%: Here's is How to Trade - Nasdaq

Mar 05, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 05, 2025

Rigel Pharmaceuticals stock holds Buy rating, $57 target By Investing.com - Investing.com South Africa

Mar 05, 2025

Rigel Pharmaceuticals stock holds Buy rating, $57 target - Investing.com India

Mar 05, 2025

B. Riley Raises Price Target on Rigel Pharmaceuticals to $24 From $20, Keeps Neutral Rating - Marketscreener.com

Mar 05, 2025

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Malaysian Reserve

Mar 05, 2025